0001127602-12-027786.txt : 20121002 0001127602-12-027786.hdr.sgml : 20121002 20121002152506 ACCESSION NUMBER: 0001127602-12-027786 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120928 FILED AS OF DATE: 20121002 DATE AS OF CHANGE: 20121002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Massingale H. Lynn CENTRAL INDEX KEY: 0001478236 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34583 FILM NUMBER: 121123147 MAIL ADDRESS: STREET 1: TEAM HEALTH HOLDINGS STREET 2: 1900 WINSTON ROAD, SUITE 300 CITY: KNOXVILLE STATE: TN ZIP: 37919 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TEAM HEALTH HOLDINGS INC. CENTRAL INDEX KEY: 0001082754 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] IRS NUMBER: 364276525 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 265 BROOKVIEW CENTRE WAY STREET 2: SUITE 400 CITY: KNOXVILLE STATE: TN ZIP: 37919 BUSINESS PHONE: 865-693-1000 MAIL ADDRESS: STREET 1: 265 BROOKVIEW CENTRE WAY STREET 2: SUITE 400 CITY: KNOXVILLE STATE: TN ZIP: 37919 FORMER COMPANY: FORMER CONFORMED NAME: TEAM HEALTH HOLDINGS LLC DATE OF NAME CHANGE: 19990325 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2012-09-28 0001082754 TEAM HEALTH HOLDINGS INC. TMH 0001478236 Massingale H. Lynn 265 BROOKVIEW CENTRE WAY SUITE 400 KNOXVILLE TN 37919 1 1 Executive Chairman Common Stock 39663 I See Footnote Stock Options (Right to Buy) 12.00 2012-09-28 2012-09-28 4 D 0 67973 26.9518 D 2019-12-15 Common Stock 67973 67073 D Stock Options (Right to Buy) 12.00 2012-10-01 2012-10-01 4 D 0 67073 27.1194 D 2019-12-15 Common Stock 67073 0 D Stock Options (Right to Buy) 13.40 2012-10-01 2012-10-01 4 D 0 14954 27.1194 D 2020-05-27 Common Stock 14954 15046 D Stock Options (Right to Buy) 14.93 2019-12-15 Common Stock 303845 303845 D Stock Options (Right to Buy) 21.64 2021-05-26 Common Stock 30000 30000 D Stock Options (Right to Buy) 22.09 2022-05-18 Common Stock 50000 50000 D These shares are held by The H. Lynn Massingale Trust, of which the Reporting Person is the trustee and sole vested beneficiary. These stock options were excerised and the option shares were sold pursuant to a 10b5-1 plan effective August 20, 2012 between Dr. Massingale and UBS Financial Services, Inc. The stock options are fully vested and excercisable. The stock options are fully vested and exercisable with respect to 50% of the underlying shares and the options shall vest 25% on each of the 3rd and 4th anniversary dates of the date of grant. The stock options are fully vested and excercisable. The stock options are fully vested and exercisable with respect to 25% of the underlying shares and shall vest and become exercisable with respect to 25% of the remaining underlying shares on each of the 2nd, 3rd and 4th anniversaries of the May 26, 2011 grant date. The stock options shall vest and become exercisable with respect to 25% of the shares initially covered by the stock options on each of the first, second, third and fourth anniversaries of the May 18, 2012 grant date. /s/ John R. Stair, attorney-in-fact for Dr. Massingale 2012-10-01